Independent education on the three medication classes — GLP-1, dual-agonist, and triple-agonist. Any medication, evaluation, and care comes from the independent licensed provider you choose, not from GLP3 Weight Loss.
The weight-loss figures above are drawn from published clinical trials — they describe what researchers observed in those studies, not results we offer, promise, or provide. Semaglutide and tirzepatide are FDA-approved; retatrutide is investigational and not FDA-approved. Only an independent licensed provider can decide whether any medication is appropriate for you.
How the three medication classes differ by mechanism and by what clinical trials reported. Educational comparison only — not treatment we provide.
| Attribute | Semaglutide | Tirzepatide | Retatrutide |
|---|---|---|---|
| Drug Class | GLP-1 agonist | GLP-1/GIP dual agonist | Triple agonist |
| Receptor Targets | GLP-1 | GLP-1 + GIP | GLP-1 + GIP + Glucagon |
| Regulatory Status | FDA-approved | FDA-approved | Investigational — not FDA-approved |
| Brand Names | Wegovy / Ozempic | Mounjaro / Zepbound | None (in trials) |
| Key Trial Program | STEP | SURMOUNT | Phase 2 (ongoing) |
| Mean Weight Loss Reported in Trials | ~15% | ~21% | ~24% (Phase 2) |
GLP3 Weight Loss is an independent educational resource. We do not prescribe, dispense, or sell treatment. Here is how a typical, fully independent path works.
Prescribing decisions are made only by an independent, third-party licensed provider you choose. GLP3 Weight Loss does not employ clinicians or see patients.
When an approved medication is prescribed, it is dispensed by a licensed pharmacy — never by GLP3 Weight Loss. Retatrutide is investigational and not available as an approved prescription.
Evaluation, dosing, monitoring, and follow-up are entirely between you and the independent provider. We do not direct or participate in your care.
Our role is to explain what each medication class is, what clinical trials reported, and which agents the FDA has approved — so you can have an informed conversation with a provider.
GLP3 Weight Loss is not a HIPAA covered entity. We do not hold protected health information or manage prescriptions on your behalf.
GLP3 Weight Loss does not sell programs, medication, consultations, or shipping. Any treatment and any fees are set by the independent licensed provider you choose.
Common questions about these medication classes and how access works.
Only a licensed provider can decide whether any of these medications is right for you. We can help you find one.
GLP3 Weight Loss is not a clinic, pharmacy, or telehealth provider. Provider referral only.